TY  - GEN
AU  - Melief,Sara M
AU  - Visconti,Valeria V
AU  - Visser,Marten
AU  - van Diepen,Merel
AU  - Kapiteijn,Ellen H W
AU  - van den Berg,Joost H
AU  - Haanen,John B A G
AU  - Smit,Vincent T H B M
AU  - Oosting,Jan
AU  - van der Burg,Sjoerd H
AU  - Verdegaal,Els M E
TI  - Long-term Survival and Clinical Benefit from Adoptive T-cell Transfer in Stage IV Melanoma Patients Is Determined by a Four-Parameter Tumor Immune Signature
SN  - 2326-6074
PY  - 2017///1122
KW  - Adult
KW  - Aged
KW  - Biomarkers
KW  - Female
KW  - Galectins
KW  - metabolism
KW  - Humans
KW  - Immunity
KW  - Immunotherapy, Adoptive
KW  - Macrophages
KW  - immunology
KW  - Male
KW  - Melanoma
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Prognosis
KW  - Survival Analysis
KW  - T-Lymphocyte Subsets
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/2326-6066.CIR-16-0288
ER  -